Skip to content
value.today

Vanta Bioscience: peers

Change the peers

Vanta Bioscience beside the 7 companies most like it by industry, size and country: every figure with its date and source, its rank in the group and its percentile in its sector and country.

Vanta Bioscience, Medinova Diagnostic Services, Dolphin Medical Services Limited, Dr Habeebullah Life Sciences Limited, Scandent Imaging, Choksi Laboratories, Aspira Pathlab & Diagnostics Limited, FOXO Technologies Inc.: the market cap on file is more than 60 days old or a last known value (no market-data feed for their exchanges yet), so their valuation multiples and yields are shown but not ranked.

Side by side#

Every figure with its fiscal year or date and its source. Switch to each company's rank in the group, or its percentile in its sector or country. How ranks are worked out.

Vanta Bioscience, Medinova Diagnostic Services, Dolphin Medical Services Limited, Dr Habeebullah Life Sciences Limited, Scandent Imaging, Choksi Laboratories, Aspira Pathlab & Diagnostics Limited, FOXO Technologies Inc. side by side: each figure with its period and source, its rank among these companies and its percentile in the company's sector and country
MeasureVanta Biosciencebase
VANTABIO.BO · 🇮🇳 IN
Percentile in Healthcare
Percentile in India
Medinova Diagnostic Services
MEDINOV.BO · 🇮🇳 IN
Percentile in Healthcare
Percentile in India
Dolphin Medical Services Limited
DOLPHMED.BO · 🇮🇳 IN
Percentile in Healthcare
Percentile in India
Dr Habeebullah Life Sciences Limited
DRHABEEB.BO · 🇮🇳 IN
Percentile in Healthcare
Percentile in India
Scandent Imaging
SCANDENT.BO · 🇮🇳 IN
Percentile in Healthcare
Percentile in India
Choksi Laboratories
CHOKSILA.BO · 🇮🇳 IN
Percentile in Healthcare
Percentile in India
Aspira Pathlab & Diagnostics Limited
ASPIRA.BO · 🇮🇳 IN
Percentile in Healthcare
Percentile in India
FOXO Technologies Inc.
FOXO · 🇺🇸 US
Percentile in Healthcare
Percentile in USA
Group median
Size
Market cap (Better neither way: ranked highest first)$2 Mlast known, Mar 8, 2026 · Market dataLast known value: no current one6th of 8$3 Mlast known, Jul 30, 2023 · Market dataLast known value: no current one5th of 8$1 Mlast known, Mar 8, 2026 · Market dataLast known value: no current one8th of 8$5 Mlast known, Jan 7, 2022 · Market dataLast known value: no current one3rd of 8$5 Mlast known, Dec 25, 2022 · Market dataLast known value: no current one3rd of 8$7 Mlast known, Mar 8, 2026 · Market dataLast known value: no current one1st of 8$7 Mlast known, Mar 8, 2026 · Market dataLast known value: no current one1st of 8$2 Mlast known, Jan 5, 2024 · Market dataLast known value: no current one6th of 8$4 M8 ranked
Revenue (Better neither way: ranked highest first)——————————————$16 MFY2025 · SEConly one with it$16 M—
Net income (Higher is better)——————————————$-12 MFY2025 · SEConly one with it$-12 M—
Employees (Better neither way: ranked highest first)——————————————192March 10, 2026 · Profileonly one with it192—
Growth
Revenue growth (Higher is better)————————————————————————————+304.2%FY2025 · SEConly one with it97th99th+304.2%—
Margins and returns
Operating margin (Higher is better)————————————————————————————-63.1%FY2025 · SEConly one with it28th13th-63.1%—
Net margin (Higher is better)————————————————————————————-75.9%FY2025 · SEConly one with it26th12th-75.9%—
Free cash flow margin (Higher is better)————————————————————————————-24.0%FY2025 · SEConly one with it36th16th-24.0%—
Return on equity (Higher is better)————————————————————————————-151.0%FY2025 · SEConly one with it16th7th-151.0%—
Financial strength
Interest cover (Higher is better)————————————————————————————-3.0×FY2025 · SEConly one with it62nd35th-3.0×—
Scorecard
Scorecard (Higher is better)——————————————1 of 8FY2025 · Scorecardonly one with it13% passed—
Growth checks (Higher is better)——————————————1 of 1FY2025 · Scorecardonly one with it100% passed—
Profitability checks (Higher is better)——————————————0 of 4FY2025 · Scorecardonly one with it0% passed—
Financial health checks (Higher is better)——————————————0 of 3FY2025 · Scorecardonly one with it0% passed—

Under each figure: its fiscal year, quarter or date, and its source. ↑ higher is better, ↓ lower is better, · better neither way (ranked highest first). Ranks count only the companies with the figure; percentiles place each company among all the companies of its own sector and country with the figure (ten or more needed).

Sources: SEC = SEC annual reports (10-K, 20-F, 40-F); ESEF = ESEF annual reports (European and UK listed companies); Editors = The company's annual report, entered by value.today editors; Wikidata = Wikidata, citing the annual report; Scorecard = value.today scorecard: thirty checks on the company's statements, worked out daily; 13F = SEC Form 13F holdings reports; SEC = Dividends declared per share in SEC 10-Q and 10-K filings; Profile = The company's latest reported headcount; Market data = Vanta Bioscience: National Stock Exchange of India, daily market-cap file; Medinova Diagnostic Services: National Stock Exchange of India, daily market-cap file; Dolphin Medical Services Limited: National Stock Exchange of India, daily market-cap file; Dr Habeebullah Life Sciences Limited: National Stock Exchange of India, daily market-cap file; Scandent Imaging: National Stock Exchange of India, daily market-cap file; Choksi Laboratories: National Stock Exchange of India, daily market-cap file; Aspira Pathlab & Diagnostics Limited: National Stock Exchange of India, daily market-cap file; FOXO Technologies Inc.: SEC closing prices (fails-to-deliver files) times the shares on the latest 10-K or 10-Q cover.

Where each stands in its sector and country: Operating margin#

The dot is the company; the line runs from the 10th to the 90th percentile of all the companies of its sector (or country) with the figure, the box holds the middle half and the tick is the median. Each company's newest fiscal year; figures that divide by the market value only with a market cap at most 60 days old. How percentiles are worked out.

Operating margin: each company's figure and its percentile in its sector and its country
CompanyOperating marginIn its sectorIn its country
Vanta Bioscience———
Medinova Diagnostic Services———
Dolphin Medical Services Limited———
Dr Habeebullah Life Sciences Limited———
Scandent Imaging———
Choksi Laboratories———
Aspira Pathlab & Diagnostics Limited———
FOXO Technologies Inc.-63.1%FY2025
28th percentile in Healthcaremedian -7.7%, 674 companies
13th percentile in USAmedian 3.5%, 2,594 companies

Revenue by fiscal year, and the rank in the group#

Revenue of the fiscal year. US dollars at each year's exchange rate; fiscal years as each company names them. Ranks: 1st is the highest (better neither way).

Revenue

$0 M$4 M$8 M$12 M$16 M2022202320242025FOXO Technologies Inc. $16 M

Rank in the group

Ranks need two fiscal years with the figure for at least two of these companies.

Revenue by fiscal year with each company's rank in the group and the source of each figure
Fiscal yearVanta BioscienceMedinova Diagnostic ServicesDolphin Medical Services LimitedDr Habeebullah Life Sciences LimitedScandent ImagingChoksi LaboratoriesAspira Pathlab & Diagnostics LimitedFOXO Technologies Inc.
2025———————$16 MSEC
2024———————$4 MSEC
2023———————$0 MSEC
2021———————$0 MSEC

Sources: SEC = SEC annual reports (10-K, 20-F, 40-F); ESEF = ESEF annual reports (European and UK listed companies); Ed. = The company's annual report, entered by value.today editors; WD = Wikidata, citing the annual report; Cap = value.today market caps (the last of each calendar year). The small ordinal is the rank in the group that year. Hover a figure for its fiscal year end.

Suggested peers of Vanta Bioscience#

Companies of the same industry, within a hundred times its size (market cap), scored out of 100 for industry, size, country and figures on file. How peers are suggested.

  • Medinova Diagnostic ServicesMEDINOV.BO · 🇮🇳 India
    Same industry: Diagnostics and Research · Similar size: $3 M market cap against $2 M · Same country: India
    Market cap $3 M (last known, Jul 30, 2023)
    92 of 100 (industry or sector 50 + size 27 + country 15)
    In the group
  • Dolphin Medical Services LimitedDOLPHMED.BO · 🇮🇳 India
    Same industry: Diagnostics and Research · Similar size: $1 M market cap against $2 M · Same country: India
    Market cap $1 M (last known, Mar 8, 2026)
    90 of 100 (industry or sector 50 + size 26 + country 15)
    In the group
  • Dr Habeebullah Life Sciences LimitedDRHABEEB.BO · 🇮🇳 India
    Same industry: Diagnostics and Research · Similar size: $5 M market cap against $2 M · Same country: India
    Market cap $5 M (last known, Jan 7, 2022)
    89 of 100 (industry or sector 50 + size 24 + country 15)
    In the group
  • Scandent ImagingSCANDENT.BO · 🇮🇳 India
    Same industry: Diagnostics and Research · Similar size: $5 M market cap against $2 M · Same country: India
    Market cap $5 M (last known, Dec 25, 2022)
    89 of 100 (industry or sector 50 + size 24 + country 15)
    In the group
  • Choksi LaboratoriesCHOKSILA.BO · 🇮🇳 India
    Same industry: Diagnostics and Research · Similar size: $7 M market cap against $2 M · Same country: India
    Market cap $7 M (last known, Mar 8, 2026)
    87 of 100 (industry or sector 50 + size 22 + country 15)
    In the group
  • Aspira Pathlab & Diagnostics LimitedASPIRA.BO · 🇮🇳 India
    Same industry: Diagnostics and Research · Similar size: $7 M market cap against $2 M · Same country: India
    Market cap $7 M (last known, Mar 8, 2026)
    87 of 100 (industry or sector 50 + size 22 + country 15)
    In the group
  • FOXO Technologies Inc.FOXO · 🇺🇸 USA
    Same industry: Diagnostics and Research · Similar size: $2 M market cap against $2 M · Ratios of the last two fiscal years on file
    Market cap $2 M (last known, Jan 5, 2024) · revenue $16 M (year to December 2025)
    85 of 100 (industry or sector 50 + size 30 + figures on file 5)
    In the group
  • Virax Biolabs Group LimitedVRAX · 🇬🇧 UK
    Same industry: Diagnostics and Research · Similar size: $2 M market cap against $2 M · Ratios of the last two fiscal years on file
    Market cap $2 M (Aug 1, 2026) · revenue $0 M (year to March 2025)
    85 of 100 (industry or sector 50 + size 30 + figures on file 5)
    + Add
  • CapForce Inc.CFOR · 🇺🇸 USA
    Same industry: Diagnostics and Research · Similar size: $4 M market cap against $2 M · Ratios of the last two fiscal years on file
    Market cap $4 M (last known, Jan 5, 2024) · revenue $30 M (year to December 2025)
    80 of 100 (industry or sector 50 + size 26 + figures on file 5)
    + Add
  • Co-Diagnostics, Inc.CODX · 🇺🇸 USA
    Same industry: Diagnostics and Research · Similar size: $4 M market cap against $2 M · Ratios of the last two fiscal years on file
    Market cap $4 M (Oct 30, 2026) · revenue $1 M (year to December 2025)
    80 of 100 (industry or sector 50 + size 25 + figures on file 5)
    + Add
  • Prostatype Genomics AB (publ)PROGEN.ST · 🇸🇪 Sweden
    Same industry: Diagnostics and Research · Similar size: $2 M market cap against $2 M
    Market cap $2 M (last known, Jan 5, 2024)
    80 of 100 (industry or sector 50 + size 30)
    + Add
  • Motus GI Holdings, Inc.MOTS · 🇺🇸 USA
    Same industry: Diagnostics and Research · Similar size: $2 M market cap against $2 M
    Market cap $2 M (last known, Jan 5, 2024)
    80 of 100 (industry or sector 50 + size 30)
    + Add

Any figure over the years, other peers or a saved group: open this group in the peer workspace.